Steven F. Bellon - 10 Jan 2022 Form 3 Insider Report for Foghorn Therapeutics Inc. (FHTX)

Role: Chief Scientific Officer
Signature: /s /Allan Reine, M.D., Attorney-in-Fact
Issuer symbol: FHTX
Transactions as of: 10 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 11 Jan 2022, 15:03:47 UTC
Next filing: 28 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	FHTX	Common Stock						115,707	10 Jan 2022	Direct
holding	FHTX	Common Stock						50,000	10 Jan 2022	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	FHTX	Stock Options (Right to buy)							10 Jan 2022	Common Stock	675	$0.7300	Direct	F2
holding	FHTX	Stock Options (Right to buy)							10 Jan 2022	Common Stock	9,291	$3.72	Direct	F3
holding	FHTX	Stock Options (Right to buy)							10 Jan 2022	Common Stock	29,730	$8.77	Direct	F4
holding	FHTX	Stock Options (Right to buy)							10 Jan 2022	Common Stock	64,864	$8.77	Direct	F4
holding	FHTX	Stock Options (Right to buy)							10 Jan 2022	Common Stock	50,000	$16.63	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares held by the Steven F. Bellon 2021 Irrevocable Trust dated December 3, 2021, of which the Reporting Person's children are the trustees.
F2	The option vested at a rate of 6.25% of the underlying shares beginning on April 1, 2018 and thereafter on the first day of each calendar quarter until the option is fully vested.
F3	The option vested as to 25% of the underlying shares of common stock on January 30, 2020, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
F4	The option shall vest as to 25% of the underlying shares of common stock on August 17, 2021, the first anniversary of the of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.
F5	The options will vest as to 25% of the underlying shares of common stock on January 28, 2022, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each calendar quarter following such first anniversary until the option is fully vested.